Showing results (1331-1340 of 4,229) with videos related to

Sort By:
Pageof 423
Discover Oncology|April 20, 2026
Clinical presentation and treatment of plasmablastic myeloma-a multicenter retrospective analysisZhenhui Lv, Xiaoqing Guo, Junjing Yin, et al.
Discover Oncology|April 17, 2026
UCHL1 promotes osteosarcoma progression via deubiquitination and stabilization of LDHBZhengShuai Lv, Zhenxing Wang, Hongchao Jing, et al.
Discover Oncology|June 3, 2026
PSMC2 drives tumor progression in nasopharyngeal carcinoma by inhibiting ferroptosis through STAT3Jin Su, Shiping Ding, Shousen Hu, et al.
Discover Oncology|June 3, 2026
A rare case report of primary intraosseous meningioma with anaplastic histologyYan Sun, Xue Hu, Deyu Hu, et al.
Discover Oncology|June 3, 2026
Proteomic stratification reveals immune metabolic heterogeneity in lung adenocarcinomaYaru Wang, Miao Miao, Qingqing Wang, et al.
Discover Oncology|June 3, 2026
An integrated machine learning and mendelian randomization approach identifies SERPING1 as a prognostic biomarker associated with CD8 + T-cell infiltration in DLBCLJinhui Wang, Zhihui Li, Xinrong Zhan, et al.
Discover Oncology|June 11, 2026
Desmoglein 2 is associated with dihydroartemisinin resistance in HeLa cervical cancer cells: a potential link to the PI3K/AKT signaling pathwayYanan Liu, Shaojuan Wang, Xiaolu Xia, et al.
Discover Oncology|June 9, 2026
AGPAT family members act as potential predictive biomarkers and therapeutic targets in cervical cancerNannan Gui, Hanyi Pan, Weijuan Lu, et al.
Discover Oncology|June 20, 2023
Survival nomogram for patients with thymic squamous cell carcinoma, based on the SEER database and an external validation cohortYelan Guan, Feiqi Xu, Shuai Zheng, et al.
Discover Oncology|June 15, 2023
AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progressionPeng Ma, Ying Hao, Wei Wang, et al.
Pageof 423